Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by CCAbbott888on May 02, 2019 8:38am
246 Views
Post# 29699457

More math for those who wish to consider the rights offer

More math for those who wish to consider the rights offerHi all, I have published a free blog on Seeking Alpha site.

I've given examples of 7 senarios, which can be considered for those who wish to consider the rights offer for their own situation.  The below is the summary table.  For more details, please go to the link above to read.  For anyone who has any question about the math, you can ask me there too if you have a seeking alpha account.  GLTA longs!

Scenario Sell at 6 cents New* money New Average cost
A no no $1
B 60% no $0.36
C 70% no

$0.33

$0.43 with $11 left over

D no $102 $0.14
E no $304 $0.06
F 60% $86** $0.13
G 70% $49** $0.17

*This is a speculative, highly risky biotech stock.  Therefore, any new money should not be money that you cannot afford to lose or may be needed soon.

**These two scenarios estimate how much new money is needed if x20 rights shares are available.  Therefore these amounts are the maximum $ needed.   
Bullboard Posts